Paper40211394
Natural killer cells: the immune frontline against circulating tumor cells.
Masmoudi D and 2 others. J Exp Clin Cancer Res, 2025. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. Natural killer cells: the immune frontline against circulating tumor cells. Papers, record 40211394. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40211394
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Killer Cells, Natural | Major topic |
| Neoplastic Cells, Circulating | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Tumor Microenvironment | |
| Animals | |
| Tumor Escape |
Source PubMed
References199
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34824036 | Crosstalk between macrophages and natural killer cells in the tumor microenvironment. | Int Immunopharmacol | 2021 | https://conductscience.org/library/papers/34824036 | PubMed |
| 2 | 39403373 | Peripheral NK cell count predicts response and prognosis in breast cancer patients underwent neoadjuvant chemotherapy. | Front Immunol | 2024 | https://conductscience.org/library/papers/39403373 | PubMed |
| 3 | 34960234 | Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34960234 | PubMed |
| 4 | 12913096 | Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. | J Exp Med | 2003 | https://conductscience.org/library/papers/12913096 | PubMed |
| 5 | 30320350 | TGF-β1 secreted by M2 phenotype macrophages enhances the stemness and migration of glioma cells via the SMAD2/3 signalling pathway. | Int J Mol Med | 2018 | https://conductscience.org/library/papers/30320350 | PubMed |
| 6 | 11117911 | Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. | Lancet | 2000 | https://conductscience.org/library/papers/11117911 | PubMed |
| 7 | 33681290 | CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma. | Front Mol Biosci | 2021 | https://conductscience.org/library/papers/33681290 | PubMed |
| 8 | 28592115 | Identification of chemokine CXCL10 in tumor microenvironment by antibody array as a prognostic marker in hepatocellular carcinoma. | Neoplasma | 2017 | https://conductscience.org/library/papers/28592115 | PubMed |
| 9 | 26873994 | Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells. | J Immunol | 2016 | https://conductscience.org/library/papers/26873994 | PubMed |
| 10 | 36706761 | Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance. | Cancer Cell | 2023 | https://conductscience.org/library/papers/36706761 | PubMed |
| 11 | 31799781 | Endogenous CXCL9 affects prognosis by regulating tumor-infiltrating natural killer cells in intrahepatic cholangiocarcinoma. | Cancer Sci | 2020 | https://conductscience.org/library/papers/31799781 | PubMed |
| 12 | 32987138 | NK cells-directed therapies target circulating tumor cells and metastasis. | Cancer Lett | 2021 | https://conductscience.org/library/papers/32987138 | PubMed |
| 13 | 3342125 | Depressed natural killer cell activity in cervical lymph nodes containing focal metastatic squamous cell carcinoma. | Arch Otolaryngol Head Neck Surg | 1988 | https://conductscience.org/library/papers/3342125 | PubMed |
| 14 | 11489331 | The physiology of the lymphatic system. | Adv Drug Deliv Rev | 2001 | https://conductscience.org/library/papers/11489331 | PubMed |
| 15 | 16230475 | CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. | J Exp Med | 2005 | https://conductscience.org/library/papers/16230475 | PubMed |
| 16 | 21953496 | The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: its impact on the chemokine expression profile, including suppression of CXCL10. | Int J Cancer | 2012 | https://conductscience.org/library/papers/21953496 | PubMed |
| 17 | 19738039 | Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. | Cancer Res | 2009 | https://conductscience.org/library/papers/19738039 | PubMed |
| 18 | 7185419 | Role of natural killer cells in control of cancer metastasis. | Cancer Metastasis Rev | 1982 | https://conductscience.org/library/papers/7185419 | PubMed |
| 19 | 27860528 | The Lymphatic System: Integral Roles in Immunity. | Annu Rev Immunol | 2017 | https://conductscience.org/library/papers/27860528 | PubMed |
| 20 | 30137312 | The role of neutrophils in cancer. | Br Med Bull | 2018 | https://conductscience.org/library/papers/30137312 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42921329 | Nanotechnology to Engineer the Surface of Immune Cells. | ACS Nanosci Au | 2026 | https://conductscience.org/library/papers/42921329 | PubMed |
| 42774839 | Blood-based tumor biomarkers: integrating biological layers and analytical strategies for precision cancer detection. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42774839 | PubMed |
| 42704135 | Engineered Natural Killer Cell Derived-Extracellular Vesicles: An Acellular Immunotherapy with Cytotoxic Effects in SNU-1079 Human Cholangiocarcinoma Cells. | Mol Pharm | 2026 | https://conductscience.org/library/papers/42704135 | PubMed |
| 42535395 | CTGF: The remodeler of the tumor immune microenvironment (Review). | Oncol Rep | 2026 | https://conductscience.org/library/papers/42535395 | PubMed |
| 42506281 | Purinergic and Energy Metabolism Disruption in Oxidative Stress-Mediated Immunotoxicity Induced by Aflatoxin B1 and Fumonisin B1. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42506281 | PubMed |
| 42495619 | Circulating immune and biochemical markers predict tumor response to immunotherapy in advanced melanoma and lung cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42495619 | PubMed |
| 42342922 | Vimentin trogocytosis as a novel mechanism of NK cell exhaustion by circulating tumor cells. | Cell Mol Immunol | 2026 | https://conductscience.org/library/papers/42342922 | PubMed |
| 42332096 | Acquisition of Vimentin by trogocytosis inhibits the NK cell-mediated immune response against circulating tumour cells (CTCs). | Cell Mol Immunol | 2026 | https://conductscience.org/library/papers/42332096 | PubMed |
| 42280307 | Dual-Protein Intervention in CT26 Tumor-Bearing Mice: A Preliminary Evaluation of Its Effects on Anti-Tumor Efficacy of 5-Fluorouracil and Immune Responses. | Nutrients | 2026 | https://conductscience.org/library/papers/42280307 | PubMed |
| 42279367 | Risk of Malignancy with Immunosuppressive Drugs Used in Organ Transplants Compared to Those Used for Non-Transplant Indications. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42279367 | PubMed |
| 42185071 | Triple-Negative Breast Cancer Cells Utilize IL8 and CXCL1 to Suppress NK Cells' Function and Facilitate Cancer Metastasis. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42185071 | PubMed |
| 42165861 | Overcoming resistance in CD44-overexpressing myeloma through combination therapy with ATRA, bortezomib, and NK cells. | Cancer Immunol Immunother | 2026 | https://conductscience.org/library/papers/42165861 | PubMed |
| 42161914 | Lactate metabolism and lactylation in cancer: from pathogenesis to therapeutic advances. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42161914 | PubMed |
| 42125695 | Low prognostic nutritional index score is associated with lymph node metastasis in patients with breast cancer, whereas hemoglobin-albumin-lymphocyte-platelet score is not. | Front Oncol | 2026 | https://conductscience.org/library/papers/42125695 | PubMed |
| 42082461 | Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42082461 | PubMed |
| 42001180 | Liquid biopsy reveals the immune status and protein profiles linked to CTC burden and clinical outcomes in metastatic breast cancer. | J Exp Clin Cancer Res | 2026 | https://conductscience.org/library/papers/42001180 | PubMed |
| 41952187 | Decoding the spatiotemporal characteristics of ferroptosis: reshaping tumour therapeutic strategies. | Exp Hematol Oncol | 2026 | https://conductscience.org/library/papers/41952187 | PubMed |
| 41770372 | Natural killer cells, macrophages and dendritic cells as innate immune therapies for blood cancers. | Ann Hematol | 2026 | https://conductscience.org/library/papers/41770372 | PubMed |
| 41751962 | Do Metastatic Cells Arise from PD-L1+ Cell Niches in Gastric Adenocarcinoma? | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41751962 | PubMed |
| 41742461 | TNF-α deficiency underlies NK cell dysfunction in colorectal cancer. | Oncoimmunology | 2026 | https://conductscience.org/library/papers/41742461 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40211394
GET https://conductscience.org/api/papers/v1/40211394/references?page=2